3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).Bioorg Med Chem Lett. 2010 Jan 01; 20(1):38-41.BM
Abstract
A comparative molecular similarity indices analysis (CoMSIA) of a set of 42 3,4-dihydroquinazolines have been performed to find out the pharmacophore elements for T-type calcium channel blocking activity. The most potent compound, 33 (KYS05090) was used to align the molecules. As a result, we obtained 3D QSAR model which provided good predictivity for the training set (q(2)=0.642, r(2)=0.874) and the test set (r(pred)(2)=0.884). This model would guide the design of new chemical entities potentially having high potency.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
19951839
Citation
Jeong, Jin Ah, et al. "3D QSAR Studies On 3,4-dihydroquinazolines as T-type Calcium Channel Blocker By Comparative Molecular Similarity Indices Analysis (CoMSIA)." Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 1, 2010, pp. 38-41.
Jeong JA, Cho H, Jung SY, et al. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA). Bioorg Med Chem Lett. 2010;20(1):38-41.
Jeong, J. A., Cho, H., Jung, S. Y., Kang, H. B., Park, J. Y., Kim, J., Choo, D. J., & Lee, J. Y. (2010). 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA). Bioorganic & Medicinal Chemistry Letters, 20(1), 38-41. https://doi.org/10.1016/j.bmcl.2009.11.049
Jeong JA, et al. 3D QSAR Studies On 3,4-dihydroquinazolines as T-type Calcium Channel Blocker By Comparative Molecular Similarity Indices Analysis (CoMSIA). Bioorg Med Chem Lett. 2010 Jan 1;20(1):38-41. PubMed PMID: 19951839.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
AU - Jeong,Jin Ah,
AU - Cho,Haelim,
AU - Jung,Soo Yeon,
AU - Kang,Han Byul,
AU - Park,Jin Yeong,
AU - Kim,Jungahn,
AU - Choo,Dong Joon,
AU - Lee,Jae Yeol,
Y1 - 2009/11/15/
PY - 2009/07/24/received
PY - 2009/10/07/revised
PY - 2009/11/12/accepted
PY - 2009/12/3/entrez
PY - 2009/12/3/pubmed
PY - 2010/5/7/medline
SP - 38
EP - 41
JF - Bioorganic & medicinal chemistry letters
JO - Bioorg Med Chem Lett
VL - 20
IS - 1
N2 - A comparative molecular similarity indices analysis (CoMSIA) of a set of 42 3,4-dihydroquinazolines have been performed to find out the pharmacophore elements for T-type calcium channel blocking activity. The most potent compound, 33 (KYS05090) was used to align the molecules. As a result, we obtained 3D QSAR model which provided good predictivity for the training set (q(2)=0.642, r(2)=0.874) and the test set (r(pred)(2)=0.884). This model would guide the design of new chemical entities potentially having high potency.
SN - 1464-3405
UR - https://www.unboundmedicine.com/medline/citation/19951839/3D_QSAR_studies_on_34_dihydroquinazolines_as_T_type_calcium_channel_blocker_by_comparative_molecular_similarity_indices_analysis__CoMSIA__
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0960-894X(09)01619-9
DB - PRIME
DP - Unbound Medicine
ER -